Abstract: A hot-fillable wide-mouth jar having an opposed pair of collapse panels that move inwardly to accommodate vacuum-induced volumetric shrinkage of the jar. The jar includes a sidewall having front and rear label panels each of a predetermined radius of curvature and each of a predetermined arcuate extent. A pair of arcuate collapse panels are located between the front and rear label panels, and each has a predetermined arcuate extent and an inset grip region affording facile handling of the jar. Desirable structural parameters are disclosed.

Abstract: An electric resistance high temperature vacuum furnace having radiant heating units evenly spaced around the sides and ends of the furnace hot zone. Pairs of units are automatically regulated both radially and longitudinally according to the temperature required by the workload in the hot zone. The units each comprise parallel aligned elements electrically connected in series at their one ends. Each element has lengthwise surfaces angularly disposed from each other to form a beam structure of high section modulus for stiffness and resistance to sagging. Also, the angles of the element surfaces facing a heat-reflective assembly substantially enable all of the energy radiated toward the assembly to be reflected into the hot zone in addition to the direct radiation from the surfaces facing the hot zone. The furnace includes a re-circulating cooling system for rapid cooling of the furnace and workload.

Abstract: A perforated bottom plate for the production of a fluidized bed within a container. The perforated bottom plate has a large number of holes through which a gaseous medium flows in order to produce the fluidized bed. For better mixing of the granular material in the fluidized bed, the perforated bottom plate is provided with evenly distributed areas in which, compared to a uniform perforation, a greater number of holes per unit of area is provided.

Abstract: Viscose filaments, preferably in staple fibre form, which have a decitex of less than 5.0 and a multi-limbed cross-section, the limbs having a length-to-width aspect ratio of at least 2:1. Examples of multi-limbed cross-sectional shapes are Y-, X-, H- and T-shapes. The fibre can be formed into woven, non-woven or knitted fabrics, and is especially useful for absorbent products.

Abstract: A method for the inspection of an article which has a relatively large surface-area and which has at least two opposing, partially transparent, outer layers and at least one intermediate layer located between the outer layers. In particular, the method is utilized to optically inspect optical data media, for instance, DVDs, having the above referenced multilayer structure. The opposing sides of the article are sensed with at least two optical receivers, and the data of the recorded image points of the one optical receiver is allocated to the data of the recorded image points of the other optical receiver in such a manner that the data of the opposing points of the article are allocated to each other and can be evaluated. An identification of a potential error in the intermediate layer is possible when the data of the opposing image points indicate an error in the case of both optical receivers.

Abstract: This invention relates to cyclic combination therapies and regimens utilizing substituted indoline derivative compounds that are antagonists of the progesterone receptor having the general structure: wherein: R1, and R2 are chosen independently from each other from H, OH; OAc; alkylaryl; alkylheteroaryl; 1-propynyl; 3-propynyl; and optionally substituted alkyl, O(alkyl); aryl; or heteroaryl groups; or R1 and R2 are joined to FORM a ring comprising —CH2(CH2)nCH2— where n=0-5; —CH2CH2CMe2CH2CH2—; —O(CH2)mCH2— where m=1-4; O(CH2)pO— where p=1-4; —CH2CH2OCH2CH2—; —CH2CH2N(H or alkyl)CH2CH2—; or R1, and R2 together comprise a double bond to CMe2; C(cycloalkyl), O, or C(cycloether); R3 is H, OH, NH2, CORA; or optionally substituted alkenyl or alkynyl groups; RA=H or optionally substituted alkyl, alkoxy, or aminoalkyl groups; R4=H, halo, CN, NH2, or optionally substituted alkyl, alkoxy, or amino

Abstract: This invention relates to cyclic combination therapies utilizing, in combination with a progestin, an estrogen, or both, progesterone receptor antagonists of the general structure: wherein the substituents are as defined herein, or pharmaceutically acceptable salt thereof.

Abstract: A technique to prevent peeling of deposits formed on the surface of the inner walls of the thin-film formation apparatus and the members inside the apparatus and to suppress particle production without contamination of the inside of the apparatus. A member for a thin-film formation apparatus having inner walls and a method for manufacturing the member is provided. A plurality of unevenness is provided on at least a portion of the surface of the member and the inner walls on which unnecessary thin films are deposited. The surfaces are subjected to masking, and then, etching processing to form the plurality of unevenness. After the etching processing the masking is removed.

Abstract: A roll-form roof ridge vent having alignment means to facilitate ease of installation. The indeterminate-length, single-sheet vent is provided with a pliable medial hinge strip, or a set of expandable live hinges, which enable the otherwise straight vent to be laterally and/or angularly repositioned from its substantially straight configuration. Thus, lateral adjustments can be made to the positioning of the vent as it is being installed so that the vent is centered throughout its length over the roof ridge. The lateral adjustments do not result in buckling of the vent or unwanted distortion.

Abstract: Nucleic acid and amino acid sequences of a BRCA1 associated protein, BAP-1, are provided. These sequences, the protein, and anti-BAP-1 antibodies are useful in therapeutics and diagnostics for cancers associated with loss of the 3p21 chromosomal region and/or inappropriate BAP-1 levels.

Abstract: This invention provides compounds of the formula: wherein A and B are independent substituents selected from S, CH or N; provided that when A is S, B is CH or N; and when B is S, A is CH or N; and A and B cannot both be CH; and when A and B both equal N, one N may be optionally substituted with an C1 to C6 alkyl group; R1 and R2 are independent substituents selected from the group of H, C1 to C6 alkyl, substituted C1 to C6 alkyl, C2 to C6 alkenyl, substituted C2 to C6 alkenyl, C2 to C6 alkynyl, substituted C2 to C6 alkynyl, C3 to C8 cycloalkyl, substituted C3 to C8 cycloalkyl, aryl, substituted aryl, heterocyclic, substituted heterocyclic, CORA, or NRBCORA; or R1 and R2 are fused to form optionally substituted 3 to 8 membered spirocyclic alkyl, alkenyl or heterocyclic ring, the heterocyclic ring containing one to three heteroatoms selected from the group of O, S and N; or pharmaceutically useful salts thereof.

Abstract: A process and apparatus for blow-molding, sterilizing, filling and capping plastic containers under conditions of positive control in a close-coupled, compact machine to enhance operational efficiency.

Abstract: A roll-form roof ridge vent having a plurality of hollow cusps and a reinforced nail line. The cusps space the upper surface of the vent from the underlying roof to provide a path of ventilation therebetween. The reinforced nail line permits the use of standard pneumatic roofing nail guns to apply nails to the vent and overlying cap shingles. The reinforced vent resists compression and prevents nail heads of nails driven into hollow cusps of the vent from sinking past the upper surface of the vent. The nail line reinforcement material can be a fabric, elastomeric or other type of material.

Abstract: A method for preventing or retarding the development atherosclerotic lesions or restenosis involves administering to a subject, preferably a human, an effective amount of an anti-viral composition directed against CMV, and optionally an anti-microbial composition directed against C. pneumoniae. These compositions may be conventional chemical anti-microbial pharmaceutics. Alternatively, the compositions may contain a cytomegalovirus (CMV) protein or fragment thereof (or nucleic acid containing compositions expressing such protein or fragment). Such compositions may contain an immunogenic C. pneumoniae protein or fragment thereof (or nucleic acid containing compositions expressing such protein or fragment). The protein/nucleic acid compositions are administered in an amount capable of inducing cell mediated immunity and/or antibody response in the subject.

Abstract: A blow-molded container (10) having a closure flap (14) formed of compressed material (32) integral with the container (10). Preferably, the container body (12) has a normally-closed fill port (16) and a dispensing port (18) which can be selectively opened and closed by the closure flap (14). The closure flap 14 is provided with multiple hinges (34, 38, 50) to allow the closure flap (14) to fold reversely upon itself and to allow the dispensing port (18) to be opened and closed while the fill port (16) remains closed.

Abstract: A replication defective recombinant adenovirus is provided which contains a complete deletion of its E1 gene and at least a partial deletion of its E3 gene, said virus containing in the site of the E1 deletion a sequence comprising a non-adenovirus promoter directing the replication and expression of DNA encoding a heterologous protein from a disease-causing agent, which, when administered to a mammal in said recombinant virus, elicits a substantially complete protective immune response against the agent. Pharmaceutical and veterinary products containing the recombinant adenovirus are provided.